Table 5.
Variables | Sensitivity, % | Specificity, % |
---|---|---|
Single‐marker panel | ||
sMICA | 76.5 | 91.2 |
sMICB | 76.9 | 90.6 |
UA | 39.6 | 88.0 |
CA19‐9 | 73.5 | 90.9 |
Two‐marker panel | ||
sMICA, sMICB | 84.6 | 92.2 |
sMICA, UA | 81.3 | 90.8 |
sMICB, UA | 72.7 | 90.2 |
sMICA, CA19‐9 | 87.8 | 89.4 |
sMICB, CA19‐9 | 84.6 | 91.9 |
CA19‐9, UA | 65.2 | 89.1 |
Three‐marker panel | ||
sMICA, sMICB, UA | 90.9 | 93.4 |
sMICA, sMICB, CA19‐9 | 92.3 | 93.5 |
sMICA, UA, CA19‐9 | 84.8 | 92.2 |
sMICB, UA, CA19‐9 | 81.8 | 91.7 |
Four‐marker panel | ||
sMICA, sMICB, UA, CA19‐9 | 94.2 | 93.3 |
CA19‐9, cancer antigen 19‐9; sMICA, soluble MHC class I chain‐related molecules A; sMICB, soluble MHC class I chain‐related molecules B; UA, uric acid.